The Scleroderma Foundation Teams Up with Traitwise PDF Print E-mail
Tuesday, 16 February 2010 14:40
The Scleroderma Foundation has teamed up with Austin, TX company, Traitwise Incorporated, to launch a unique survey to poll thousands of scleroderma patients and their caregivers. Data from the survey will be shared with researchers nationally and internationally in an effort to improve understanding and treatment of scleroderma.

By gathering answers about everything from symptoms to family history of disease to quality of life - and then comparing every answer to every other answer - the survey mechanism promises to tease out previously unsuspected patterns that can lead to new diagnostics, treatments, and even a cure for this chronic autoimmune disease that afflicts approximately one in every thousand people.

"As common as it is and despite the heroic efforts of clinicians and researchers, scleroderma still isn't well understood," said Scleroderma Foundation CEO Robert Riggs. "The Traitwise survey gives us a chance to assemble and analyze more pieces of the puzzle and really move research forward."

The unique Traitwise approach to data security allows users to volunteer information without fear that the information will be shared or used to identify them. Once it's made anonymous, data will be made available to researchers through the Scleroderma Foundation. "We understand that the information we seek is sensitive and personal," said Executive Vice President Michael Simpson of Traitwise. "So we answer every user's privacy expectation with an iron-clad commitment to protect their personal information."

Source: MMD Newswire
 
More articles :

» Facing Life's Challenges

At 57 years of age Anne Wersching doesn’t have a single wrinkle on her face.Sitting in her lounge room in Bayswater North, Ms Wersching looks well, save for a few red marks on her cheeks.But Ms Wersching has a little-known disease called...

» DETECT Algorithm Increases Rate Of Diagnosis For PAH In Scleroderma Patients

The use of a two-step algorithm significantly increased the rate at which pulmonary arterial hypertension was diagnosed in patients with in a prospective, observational, cross-sectional study. The results of the , presented at the annual European...

» African Americans Have More Severe Complications From Scleroderma

African Americans have more severe complications from systemic sclerosis, also known as scleroderma, than Caucasians. Findings published today in, , a journal of the American College of Rheumatology (ACR), show that compared with Caucasians,...

» Preliminary Results Show Beneficial Effects of Imatinib in Scleroderma

Imatinib (Gleevec), a drug that has significantly improved survival in chronic myelogenous leukemia and gastrointestinal stromal tumor, is showing beneficial effects on skin and lung manifestations in patients with diffuse cutaneous scleroderma....

» Scleroderma and the Kidney

John F Donohoe Principle DiscussantPublished: Kidney International (1992) 41, 462–477; doi:10.1038/ki.1992.65Source: http://www.nature.com/ki/journal/v41/n2/abs/ki199265a.html

» Low-Dose Naltrexone for Pruritus in Systemic Sclerosis

Tracy Frech, Kirsten Novak, Monica P. Revelo, Maureen Murtaugh, Boaz Markewitz, Nathan Hatton, Mary Beth Scholand, Edward Frech, David Markewitz, and Allen D. SawitzkeReceived 31 May 2011; Accepted 14 July 2011Systemic sclerosis (SSc; scleroderma)...